More recently, in an HFpEF-like model combining obesity, hypertension, and mild pressure overload, chronic PDE9A inhibition similarly reduced myocardial collagen deposition by ~60% and suppressed pro-fibrotic gene expression [28]. Here, PDE9A is linked to hypertensive disorder.